Further development by Ohr Sample Clauses

Further development by Ohr. Ohr shall own all intellectual property and clinical trial data it develops independently. Ohr grants Angion an option to an exclusive, worldwide, sub-licensable and transferable license to any uses of Ohr’s intellectual property outside the Licensed Field for further development and to make, have made, use, sell, offer for sale, import and otherwise exploit products. The option shall extend for [***] ([***]) days after Angion’s receipt of a disclosure of the intellectual property (the “Option Period”). If Angion notifies Ohr in writing of its exercise of the option within the Option Period, then the parties will proceed in good faith to negotiate a license agreement within [***] ([***]) days after notification of exercise (“Negotiation Period”). If Angion does not exercise its option, or notifies Ohr that it will not exercise its option, or the parties fail to sign a license agreement within the Negotiation Period, then Angion shall no longer have any claim to Ohr’s disclosed intellectual property outside the Licensed Field, except that if the parties are unable to agree on licensing terms during the Negotiation Period, then for a period of [***] ([***])[***] thereafter Ohr shall not license the intellectual property to a third party on financial terms more favorable to the licensee than those last offered to Angion without first giving Angion an opportunity to license the intellectual property or data on those more favorable terms. Upon Notification, Angion will have [***] ([***]) days to accept the licensing terms deemed more favorable.
Sample 1Sample 2
AutoNDA by SimpleDocs
Further development by Ohr. Ohr shall own all intellectual property not resulting from the Licensed Patent Rights and clinical trial data it develops independently. …” ARTICLE 9 – GENERAL The contact information in Section 9.2 of the Agreement for Ohr is amended as follows: “If to Ohr: Ohr Cosmetics LLC 0 Xxxxx Xxxxxx, Xxxxx 0X Xxx Xxxx XX 00000 If to Angion: Angion Biomedica Corp. 00 Xxxxxxx Xxxxxxxxx Boulevard Uniondale, NY 15533 With copy for Notice purposes only to: On behalf of Angion Biomedica Corp. DocuSign Envelope ID: 643EFA0F-2014-4FF9-A4D1-603C4EE9C638
Sample 1
Further development by Ohr. Ohr shall own all intellectual property and clinical trial data it develops independently. Ohr grants Angion an option to an exclusive, worldwide, sub­ licensable and transferable license to any uses ofOhr's intellectual property outside the Licensed Field for further development and to make, have made, use, sell, offer for sale, import and otherwise exploit products. The option shall extend for sixty (60) days after Xxxxxx'x receipt of 10
Sample 1

Related to Further development by Ohr

  • Development Diligence Pfizer will use its Commercially Reasonable Efforts to Develop and seek Regulatory Approval for [ * ] Product [ * ] in the Field [ * ]. Pfizer will [ * ] with respect to the Development or Regulatory Approval of Products under this Agreement.

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Development Work Do, or cause to be done, such development and other work as may be reasonably necessary to protect from diminution and production capacity of the Mortgaged Property and each producing well thereon.

  • Assignment of Developments I agree that I will, without additional compensation, promptly make full written disclosure to the Company, and will hold in trust for the sole right and benefit of the Company all developments, original works of authorship, inventions, concepts, know-how, improvements, trade secrets, and similar proprietary rights, whether or not patentable or registrable under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or have solely or jointly conceived or developed or reduced to practice, or have caused or may cause to be conceived or developed or reduced to practice, during the Assignment Period, whether or not during regular working hours, provided they either (i) relate at the time of conception, development or reduction to practice to the business of any member of the Company Group, or the actual or anticipated research or development of any member of the Company Group; (ii) result from or relate to any work performed for any member of the Company Group; or (iii) are developed through the use of equipment, supplies, or facilities of any member of the Company Group, or any Confidential Information, or in consultation with personnel of any member of the Company Group (collectively referred to as “Developments”). I further acknowledge that all Developments made by me (solely or jointly with others) within the scope of and during the Assignment Period are “works made for hire” (to the greatest extent permitted by applicable law) for which I am, in part, compensated by my salary, unless regulated otherwise by law, but that, in the event any such Development is deemed not to be a work made for hire, I hereby assign to the Company, or its designee, all my right, title, and interest throughout the world in and to any such Development.

  • Development Activities NovaDel shall not be required to commence any Development Activities until Licensee has paid at least twenty-five percent (25%) of the non-refundable License Fee described in Section 4.4.

  • Notice of Developments Each Party will give prompt written notice to the other of any material adverse development causing a breach of any of its own representations and warranties in Section 3 and Section 4 above. No disclosure by any Party pursuant to this Section 5(f), however, shall be deemed to amend or supplement the Disclosure Schedule or to prevent or cure any misrepresentation, breach of warranty, or breach of covenant.

  • Development Agreement That certain Development Agreement dated of even date herewith by and between the Company and Developer providing for the development of the Project on the Property, a copy of which is attached hereto as Exhibit C and incorporated herein by reference. Development Fee. As described in Section 6.8.

  • Development of the Project The Board of Managers shall take such actions as shall be required to cause either the Company or the Management Company (as defined in Section 9(b) below) to perform and complete the construction and other development work as contemplated and/or required under the NVR Purchase and Sale Agreements, or any other construction company selected by the Board of Managers (the “Development Work”), substantially in accordance with the Project Plan, at a cost to the Company not exceeding the total cost set forth in the Budget, in a manner consistent with this Agreement and all applicable laws, ordinances, rules, regulations or requirements (including, without limitation, those with respect to discrimination) of governmental authorities, and in compliance with any covenants, conditions or restrictions affecting all or any portion of the Property.

  • Development Services Licensee may from time to time wish to augment the RMSS product with additional functionality or utility, or to integrate it with Licensee systems from other sources, and for such purposes may request the provision of development services from RMSS.

  • Joint Development All inventions, know-how, trade secrets, data or information which result from joint development by the Parties hereto shall be jointly owned by the Parties. The Parties hereby agree to cooperate in good faith in the filing of any and all patent applications in all jurisdictions.

Time is Money Join Law Insider Premium to draft better contracts faster.